Context Capital Management’s TriSalus Life Sciences Warrant TLSIW Stock Holding History

Context Capital Management’s Portfolio TLSIW Stock Details TLSIW Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q4	–	Sell	-70,426	Closed	-$27K	–	285
2023 Q3	$27K	Hold	70,426	–	–	﹤0.01%	167
2023 Q2	$3K	Hold	70,426	–	–	﹤0.01%	273
2023 Q1	$4K	Hold	70,426	–	–	﹤0.01%	305
2022 Q4	$5K	Hold	70,426	–	–	﹤0.01%	358
2022 Q3	$4K	Hold	70,426	–	–	﹤0.01%	522
2022 Q2	$6K	Hold	70,426	–	–	﹤0.01%	549
2022 Q1	$18K	Hold	70,426	–	–	﹤0.01%	592
2021 Q4	$37K	Hold	70,426	–	–	﹤0.01%	491
2021 Q3	$58K	Hold	70,426	–	–	0.01%	403
2021 Q2	$72K	Hold	70,426	–	–	0.01%	449
2021 Q1	$77K	Buy	+70,426	New	+$127K	0.01%	407

Other funds holding TLSIW

Magnetar Financial Evanston, Illinois $9.84B AUM 190.64% 1-Year Est. Return

HCM

Highbridge Capital Management New York $3.09B AUM 31.19% 1-Year Est. Return

Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return

PAMP

Polar Asset Management Partners Toronto, Ontario, Canada $5.01B AUM 35.27% 1-Year Est. Return

ETH

Exos TFP Holdings New York $162M AUM 16.08% 1-Year Est. Return

Vestcor Inc Fredericton, New Brunswick, Canada $3.63B AUM 21.49% 1-Year Est. Return

MSD Partners New York $82.3M AUM 15.13% 1-Year Est. Return

Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return

WAM

Wolverine Asset Management Chicago, Illinois $10.4B AUM 4.78% 1-Year Est. Return

BCL

Bracebridge Capital LLC Boston, Massachusetts $3.73B AUM 33.02% 1-Year Est. Return

Context Capital Management's TLSIW Position: Q4 2023 in Review

Context Capital Management sold out of TriSalus Life Sciences Warrant (TLSIW) in Q4 2023, closing a stake of 70,426 shares — an estimated $27K sold.

Context Capital Management first reported a position in TLSIW in Q1 2021 and held it in 11 quarters. The position peaked at $77K in Q1 2021. 22 funds tracked by Wall St. Rank hold TLSIW as of Q4 2023.

Context Capital Management reported no remaining TriSalus Life Sciences Warrant position as of Q4 2023 after selling out during the quarter.
Context Capital Management sold 70,426 TriSalus Life Sciences Warrant shares in Q4 2023, an estimated $27K.
Context Capital Management first reported a position in TriSalus Life Sciences Warrant in Q1 2021 and held it in 11 quarters.
Context Capital Management's TriSalus Life Sciences Warrant position peaked at $77K in Q1 2021.
22 funds tracked by Wall St. Rank held TriSalus Life Sciences Warrant as of Q4 2023.

Based on Context Capital Management's 13F filing for Q4 2023, filed 9 Feb 2024.